Trial · NCT02937506
Patient Satisfaction With Propofol for Out Patient Colonoscopy
NCT02937506, Phase 4, Completed, Mount Carmel Health System; results first posted 2017-09-27
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Patient Satisfaction With Propofol for Out Patient Colonoscopy. Trials, record NCT02937506. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02937506
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Patient Satisfaction With Propofol for Out Patient Colonoscopy
- NCT number
- NCT02937506
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 600 participants, actual
- Lead sponsor
- Mount Carmel Health System
- Conditions
- Colon Cancer, IBS, Polyps
- Interventions
- Propofol, Fentanyl Plus Midazolam
- First posted
- 2016-10-18
- Last updated
- 2017-12-26
- Results first posted
- 2017-09-27
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Patient Satisfaction | Patient satisfaction was assessed the day of the procedure. | Satisfaction assessed using self-developed questionnaire. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Patient Satisfaction | Patient satisfaction was assessed the day of the procedure. | Same as enrolled. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Patient Satisfaction | Propofol | Very Satisfied | 259 | Participants | |
| Patient Satisfaction | Fentanyl Plus Midazolam Only | Very Satisfied | 222 | Participants | |
| Patient Satisfaction | Propofol | Satisfied | 37 | Participants | |
| Patient Satisfaction | Fentanyl Plus Midazolam Only | Satisfied | 66 | Participants | |
| Patient Satisfaction | Propofol | Neutral/Less than satisfied | 4 | Participants | |
| Patient Satisfaction | Fentanyl Plus Midazolam Only | Neutral/Less than satisfied | 12 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Propofol | 300 | |
| Overall Study | STARTED | Fentanyl Plus Midazolam Only | 300 | |
| Overall Study | COMPLETED | Propofol | 300 | |
| Overall Study | COMPLETED | Fentanyl Plus Midazolam Only | 300 | |
| Overall Study | NOT COMPLETED | Propofol | 0 | |
| Overall Study | NOT COMPLETED | Fentanyl Plus Midazolam Only | 0 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea/Emesis | Gastrointestinal disorders | Propofol | 7 | 300 | 300 |
| other | Nausea/Emesis | Gastrointestinal disorders | Fentanyl Plus Midazolam Only | 17 | 300 | 300 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Propofol | 0 | 300 |
| Total, all-cause mortality | Fentanyl Plus Midazolam Only | 0 | 300 |
| Total, other adverse events | Propofol | 7 | 300 |
| Total, other adverse events | Fentanyl Plus Midazolam Only | 17 | 300 |
| Total, serious adverse events | Propofol | 0 | 300 |
| Total, serious adverse events | Fentanyl Plus Midazolam Only | 0 | 300 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Propofol vs Fentanyl Plus Midazolam Only: deaths from any cause | Trial comparisons |
| Propofol vs Fentanyl Plus Midazolam Only: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02937506
GET https://conductscience.org/api/trials/v1/NCT02937506/registered